Covid-19 Impact on Global Diabetes Devices and Drugs Market Size, Status and Forecast 2020-2026
Diabetes Devices and Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Devices and Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Diabetes Devices and Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Diabetes Devices and Drugs industry.
The key players covered in this study
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Diabetes Devices and Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Diabetes Devices and Drugs industry.
The key players covered in this study
- Medtronic
- BD
- Johnson & Johnson
- Abbott Laboratories
- Novo Nordisk
- Bristol-Myers Squibb
- DexCom
- Companion Medical
- GlaxoSmithKline
- Glenmark Pharmaceuticals
- Novartis
- Roche
- Sanofi
- MSD
- Astrazeneca
- Takeda
- North China Pharmaceutical Group Corporation
- Huadong Medicine
- Dongbao Pharmaceutical
- Hisun Pharmacy
- KELUN
- Ginwa
- Tianan Pharmaceutical
- Diabetes Devices
- Diabetes Drugs
- Diagnostic/Clinics
- ICUs
- Home Healthcare
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Diabetes Devices and Drugs status, future forecast, growth opportunity, key market and key players.
- To present the Diabetes Devices and Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To define, describe and forecast the market by type, market and key regions.
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Devices and Drugs Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diabetes Devices
1.4.3 Diabetes Drugs
1.5 Market by Application
1.5.1 Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic/Clinics
1.5.3 ICUs
1.5.4 Home Healthcare
1.6 Coronavirus Disease 2019 (Covid-19): Diabetes Devices and Drugs Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Covid-19 Implications on Global Diabetes Devices and Drugs Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Diabetes Devices and Drugs Growth Trends by Regions
2.2.1 Diabetes Devices and Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Devices and Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Devices and Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Devices and Drugs Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Diabetes Devices and Drugs Players by Market Size
3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2015-2020)
3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Devices and Drugs Market Concentration Ratio
3.2.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2019
3.3 Diabetes Devices and Drugs Key Players Head office and Area Served
3.4 Key Players Diabetes Devices and Drugs Product Solution and Service
3.5 Date of Enter into Diabetes Devices and Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)
4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2021-2026)
5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Diabetes Devices and Drugs Market Size by Application (2015-2020)
5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA IMPACT OF COVID-19
6.1 North America Diabetes Devices and Drugs Market Size (2015-2020)
6.2 Diabetes Devices and Drugs Key Players in North America (2019-2020)
6.3 North America Diabetes Devices and Drugs Market Size by Type (2015-2020)
6.4 North America Diabetes Devices and Drugs Market Size by Application (2015-2020)
7 EUROPE IMPACT OF COVID-19
7.1 Europe Diabetes Devices and Drugs Market Size (2015-2020)
7.2 Diabetes Devices and Drugs Key Players in Europe (2019-2020)
7.3 Europe Diabetes Devices and Drugs Market Size by Type (2015-2020)
7.4 Europe Diabetes Devices and Drugs Market Size by Application (2015-2020)
8 CHINA IMPACT OF COVID-19
8.1 China Diabetes Devices and Drugs Market Size (2015-2020)
8.2 Diabetes Devices and Drugs Key Players in China (2019-2020)
8.3 China Diabetes Devices and Drugs Market Size by Type (2015-2020)
8.4 China Diabetes Devices and Drugs Market Size by Application (2015-2020)
9 JAPAN IMPACT OF COVID-19
9.1 Japan Diabetes Devices and Drugs Market Size (2015-2020)
9.2 Diabetes Devices and Drugs Key Players in Japan (2019-2020)
9.3 Japan Diabetes Devices and Drugs Market Size by Type (2015-2020)
9.4 Japan Diabetes Devices and Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA IMPACT OF COVID-19
10.1 Southeast Asia Diabetes Devices and Drugs Market Size (2015-2020)
10.2 Diabetes Devices and Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Devices and Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Devices and Drugs Market Size by Application (2015-2020)
11 INDIA IMPACT OF COVID-19
11.1 India Diabetes Devices and Drugs Market Size (2015-2020)
11.2 Diabetes Devices and Drugs Key Players in India (2019-2020)
11.3 India Diabetes Devices and Drugs Market Size by Type (2015-2020)
11.4 India Diabetes Devices and Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19
12.1 Central & South America Diabetes Devices and Drugs Market Size (2015-2020)
12.2 Diabetes Devices and Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Devices and Drugs Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Devices and Drugs Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview and Its Total Revenue
13.1.3 Medtronic Diabetes Devices and Drugs Introduction
13.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2015-2020))
13.1.5 Medtronic Recent Development and Reaction to COVID-19
13.2 BD
13.2.1 BD Company Details
13.2.2 BD Business Overview and Its Total Revenue
13.2.3 BD Diabetes Devices and Drugs Introduction
13.2.4 BD Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.2.5 BD Recent Development and Reaction to COVID-19
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
13.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
13.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development and Reaction to COVID-19
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
13.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
13.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development and Reaction to COVID-19
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Details
13.5.2 Novo Nordisk Business Overview and Its Total Revenue
13.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
13.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.5.5 Novo Nordisk Recent Development and Reaction to COVID-19
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
13.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development and Reaction to COVID-19
13.7 DexCom
13.7.1 DexCom Company Details
13.7.2 DexCom Business Overview and Its Total Revenue
13.7.3 DexCom Diabetes Devices and Drugs Introduction
13.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.7.5 DexCom Recent Development and Reaction to COVID-19
13.8 Companion Medical
13.8.1 Companion Medical Company Details
13.8.2 Companion Medical Business Overview and Its Total Revenue
13.8.3 Companion Medical Diabetes Devices and Drugs Introduction
13.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.8.5 Companion Medical Recent Development and Reaction to COVID-19
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
13.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
13.10 Glenmark Pharmaceuticals
13.10.1 Glenmark Pharmaceuticals Company Details
13.10.2 Glenmark Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
13.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.10.5 Glenmark Pharmaceuticals Recent Development and Reaction to COVID-19
13.11 Novartis
10.11.1 Novartis Company Details
10.11.2 Novartis Business Overview and Its Total Revenue
10.11.3 Novartis Diabetes Devices and Drugs Introduction
10.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.11.5 Novartis Recent Development and Reaction to COVID-19
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview and Its Total Revenue
10.12.3 Roche Diabetes Devices and Drugs Introduction
10.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.12.5 Roche Recent Development and Reaction to COVID-19
13.13 Sanofi
10.13.1 Sanofi Company Details
10.13.2 Sanofi Business Overview and Its Total Revenue
10.13.3 Sanofi Diabetes Devices and Drugs Introduction
10.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.13.5 Sanofi Recent Development and Reaction to COVID-19
13.14 MSD
10.14.1 MSD Company Details
10.14.2 MSD Business Overview and Its Total Revenue
10.14.3 MSD Diabetes Devices and Drugs Introduction
10.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.14.5 MSD Recent Development and Reaction to COVID-19
13.15 Astrazeneca
10.15.1 Astrazeneca Company Details
10.15.2 Astrazeneca Business Overview and Its Total Revenue
10.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
10.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.15.5 Astrazeneca Recent Development and Reaction to COVID-19
13.16 Takeda
10.16.1 Takeda Company Details
10.16.2 Takeda Business Overview and Its Total Revenue
10.16.3 Takeda Diabetes Devices and Drugs Introduction
10.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.16.5 Takeda Recent Development and Reaction to COVID-19
13.17 North China Pharmaceutical Group Corporation
10.17.1 North China Pharmaceutical Group Corporation Company Details
10.17.2 North China Pharmaceutical Group Corporation Business Overview and Its Total Revenue
10.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
10.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.17.5 North China Pharmaceutical Group Corporation Recent Development and Reaction to COVID-19
13.18 Huadong Medicine
10.18.1 Huadong Medicine Company Details
10.18.2 Huadong Medicine Business Overview and Its Total Revenue
10.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
10.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.18.5 Huadong Medicine Recent Development and Reaction to COVID-19
13.19 Dongbao Pharmaceutical
10.19.1 Dongbao Pharmaceutical Company Details
10.19.2 Dongbao Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
10.19.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.19.5 Dongbao Pharmaceutical Recent Development and Reaction to COVID-19
13.20 Hisun Pharmacy
10.20.1 Hisun Pharmacy Company Details
10.20.2 Hisun Pharmacy Business Overview and Its Total Revenue
10.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
10.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.20.5 Hisun Pharmacy Recent Development and Reaction to COVID-19
13.21 KELUN
10.21.1 KELUN Company Details
10.21.2 KELUN Business Overview and Its Total Revenue
10.21.3 KELUN Diabetes Devices and Drugs Introduction
10.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.21.5 KELUN Recent Development and Reaction to COVID-19
13.22 Ginwa
10.22.1 Ginwa Company Details
10.22.2 Ginwa Business Overview and Its Total Revenue
10.22.3 Ginwa Diabetes Devices and Drugs Introduction
10.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.22.5 Ginwa Recent Development and Reaction to COVID-19
13.23 Tianan Pharmaceutical
10.23.1 Tianan Pharmaceutical Company Details
10.23.2 Tianan Pharmaceutical Business Overview and Its Total Revenue
10.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
10.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.23.5 Tianan Pharmaceutical Recent Development and Reaction to COVID-19
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Devices and Drugs Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diabetes Devices
1.4.3 Diabetes Drugs
1.5 Market by Application
1.5.1 Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic/Clinics
1.5.3 ICUs
1.5.4 Home Healthcare
1.6 Coronavirus Disease 2019 (Covid-19): Diabetes Devices and Drugs Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Covid-19 Implications on Global Diabetes Devices and Drugs Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Diabetes Devices and Drugs Growth Trends by Regions
2.2.1 Diabetes Devices and Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Devices and Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Devices and Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Devices and Drugs Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Diabetes Devices and Drugs Players by Market Size
3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2015-2020)
3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Devices and Drugs Market Concentration Ratio
3.2.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2019
3.3 Diabetes Devices and Drugs Key Players Head office and Area Served
3.4 Key Players Diabetes Devices and Drugs Product Solution and Service
3.5 Date of Enter into Diabetes Devices and Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)
4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2021-2026)
5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Diabetes Devices and Drugs Market Size by Application (2015-2020)
5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA IMPACT OF COVID-19
6.1 North America Diabetes Devices and Drugs Market Size (2015-2020)
6.2 Diabetes Devices and Drugs Key Players in North America (2019-2020)
6.3 North America Diabetes Devices and Drugs Market Size by Type (2015-2020)
6.4 North America Diabetes Devices and Drugs Market Size by Application (2015-2020)
7 EUROPE IMPACT OF COVID-19
7.1 Europe Diabetes Devices and Drugs Market Size (2015-2020)
7.2 Diabetes Devices and Drugs Key Players in Europe (2019-2020)
7.3 Europe Diabetes Devices and Drugs Market Size by Type (2015-2020)
7.4 Europe Diabetes Devices and Drugs Market Size by Application (2015-2020)
8 CHINA IMPACT OF COVID-19
8.1 China Diabetes Devices and Drugs Market Size (2015-2020)
8.2 Diabetes Devices and Drugs Key Players in China (2019-2020)
8.3 China Diabetes Devices and Drugs Market Size by Type (2015-2020)
8.4 China Diabetes Devices and Drugs Market Size by Application (2015-2020)
9 JAPAN IMPACT OF COVID-19
9.1 Japan Diabetes Devices and Drugs Market Size (2015-2020)
9.2 Diabetes Devices and Drugs Key Players in Japan (2019-2020)
9.3 Japan Diabetes Devices and Drugs Market Size by Type (2015-2020)
9.4 Japan Diabetes Devices and Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA IMPACT OF COVID-19
10.1 Southeast Asia Diabetes Devices and Drugs Market Size (2015-2020)
10.2 Diabetes Devices and Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Devices and Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Devices and Drugs Market Size by Application (2015-2020)
11 INDIA IMPACT OF COVID-19
11.1 India Diabetes Devices and Drugs Market Size (2015-2020)
11.2 Diabetes Devices and Drugs Key Players in India (2019-2020)
11.3 India Diabetes Devices and Drugs Market Size by Type (2015-2020)
11.4 India Diabetes Devices and Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19
12.1 Central & South America Diabetes Devices and Drugs Market Size (2015-2020)
12.2 Diabetes Devices and Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Devices and Drugs Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Devices and Drugs Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview and Its Total Revenue
13.1.3 Medtronic Diabetes Devices and Drugs Introduction
13.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2015-2020))
13.1.5 Medtronic Recent Development and Reaction to COVID-19
13.2 BD
13.2.1 BD Company Details
13.2.2 BD Business Overview and Its Total Revenue
13.2.3 BD Diabetes Devices and Drugs Introduction
13.2.4 BD Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.2.5 BD Recent Development and Reaction to COVID-19
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
13.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
13.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development and Reaction to COVID-19
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
13.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
13.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development and Reaction to COVID-19
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Details
13.5.2 Novo Nordisk Business Overview and Its Total Revenue
13.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
13.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.5.5 Novo Nordisk Recent Development and Reaction to COVID-19
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
13.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development and Reaction to COVID-19
13.7 DexCom
13.7.1 DexCom Company Details
13.7.2 DexCom Business Overview and Its Total Revenue
13.7.3 DexCom Diabetes Devices and Drugs Introduction
13.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.7.5 DexCom Recent Development and Reaction to COVID-19
13.8 Companion Medical
13.8.1 Companion Medical Company Details
13.8.2 Companion Medical Business Overview and Its Total Revenue
13.8.3 Companion Medical Diabetes Devices and Drugs Introduction
13.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.8.5 Companion Medical Recent Development and Reaction to COVID-19
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
13.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
13.10 Glenmark Pharmaceuticals
13.10.1 Glenmark Pharmaceuticals Company Details
13.10.2 Glenmark Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
13.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2015-2020)
13.10.5 Glenmark Pharmaceuticals Recent Development and Reaction to COVID-19
13.11 Novartis
10.11.1 Novartis Company Details
10.11.2 Novartis Business Overview and Its Total Revenue
10.11.3 Novartis Diabetes Devices and Drugs Introduction
10.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.11.5 Novartis Recent Development and Reaction to COVID-19
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview and Its Total Revenue
10.12.3 Roche Diabetes Devices and Drugs Introduction
10.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.12.5 Roche Recent Development and Reaction to COVID-19
13.13 Sanofi
10.13.1 Sanofi Company Details
10.13.2 Sanofi Business Overview and Its Total Revenue
10.13.3 Sanofi Diabetes Devices and Drugs Introduction
10.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.13.5 Sanofi Recent Development and Reaction to COVID-19
13.14 MSD
10.14.1 MSD Company Details
10.14.2 MSD Business Overview and Its Total Revenue
10.14.3 MSD Diabetes Devices and Drugs Introduction
10.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.14.5 MSD Recent Development and Reaction to COVID-19
13.15 Astrazeneca
10.15.1 Astrazeneca Company Details
10.15.2 Astrazeneca Business Overview and Its Total Revenue
10.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
10.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.15.5 Astrazeneca Recent Development and Reaction to COVID-19
13.16 Takeda
10.16.1 Takeda Company Details
10.16.2 Takeda Business Overview and Its Total Revenue
10.16.3 Takeda Diabetes Devices and Drugs Introduction
10.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.16.5 Takeda Recent Development and Reaction to COVID-19
13.17 North China Pharmaceutical Group Corporation
10.17.1 North China Pharmaceutical Group Corporation Company Details
10.17.2 North China Pharmaceutical Group Corporation Business Overview and Its Total Revenue
10.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
10.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.17.5 North China Pharmaceutical Group Corporation Recent Development and Reaction to COVID-19
13.18 Huadong Medicine
10.18.1 Huadong Medicine Company Details
10.18.2 Huadong Medicine Business Overview and Its Total Revenue
10.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
10.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.18.5 Huadong Medicine Recent Development and Reaction to COVID-19
13.19 Dongbao Pharmaceutical
10.19.1 Dongbao Pharmaceutical Company Details
10.19.2 Dongbao Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
10.19.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.19.5 Dongbao Pharmaceutical Recent Development and Reaction to COVID-19
13.20 Hisun Pharmacy
10.20.1 Hisun Pharmacy Company Details
10.20.2 Hisun Pharmacy Business Overview and Its Total Revenue
10.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
10.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.20.5 Hisun Pharmacy Recent Development and Reaction to COVID-19
13.21 KELUN
10.21.1 KELUN Company Details
10.21.2 KELUN Business Overview and Its Total Revenue
10.21.3 KELUN Diabetes Devices and Drugs Introduction
10.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.21.5 KELUN Recent Development and Reaction to COVID-19
13.22 Ginwa
10.22.1 Ginwa Company Details
10.22.2 Ginwa Business Overview and Its Total Revenue
10.22.3 Ginwa Diabetes Devices and Drugs Introduction
10.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.22.5 Ginwa Recent Development and Reaction to COVID-19
13.23 Tianan Pharmaceutical
10.23.1 Tianan Pharmaceutical Company Details
10.23.2 Tianan Pharmaceutical Business Overview and Its Total Revenue
10.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
10.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020)
10.23.5 Tianan Pharmaceutical Recent Development and Reaction to COVID-19
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Diabetes Devices and Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Devices and Drugs Revenue
Table 3. Ranking of Global Top Diabetes Devices and Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Devices and Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diabetes Devices
Table 6. Key Players of Diabetes Drugs
Table 7. COVID-19 Impact Global Market: (Four Diabetes Devices and Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Diabetes Devices and Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Diabetes Devices and Drugs Players to Combat Covid-19 Impact
Table 12. Global Diabetes Devices and Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Diabetes Devices and Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Diabetes Devices and Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Diabetes Devices and Drugs Market Share by Regions (2015-2020)
Table 16. Global Diabetes Devices and Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Diabetes Devices and Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Diabetes Devices and Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Diabetes Devices and Drugs Players
Table 23. Global Diabetes Devices and Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Diabetes Devices and Drugs Market Share by Players (2015-2020)
Table 25. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2019)
Table 26. Global Diabetes Devices and Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Diabetes Devices and Drugs Product Solution and Service
Table 29. Date of Enter into Diabetes Devices and Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Diabetes Devices and Drugs Market Size Share by Type (2015-2020)
Table 33. Global Diabetes Devices and Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Diabetes Devices and Drugs Market Size Share by Application (2015-2020)
Table 35. Global Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Diabetes Devices and Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 39. North America Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 41. North America Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 45. Europe Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 47. Europe Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 51. China Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 53. China Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 57. Japan Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 59. Japan Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 63. Southeast Asia Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 69. India Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 71. India Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 75. Central & South America Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 79. Medtronic Company Details
Table 80. Medtronic Business Overview
Table 81. Medtronic Product
Table 82. Medtronic Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 83. Medtronic Recent Development
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD Product
Table 87. BD Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 88. BD Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Product
Table 97. Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 98. Abbott Laboratories Recent Development
Table 99. Novo Nordisk Company Details
Table 100. Novo Nordisk Business Overview
Table 101. Novo Nordisk Product
Table 102. Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 103. Novo Nordisk Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. DexCom Company Details
Table 110. DexCom Business Overview
Table 111. DexCom Product
Table 112. DexCom Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 113. DexCom Recent Development
Table 114. Companion Medical Business Overview
Table 115. Companion Medical Product
Table 116. Companion Medical Company Details
Table 117. Companion Medical Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 118. Companion Medical Recent Development
Table 119. GlaxoSmithKline Company Details
Table 120. GlaxoSmithKline Business Overview
Table 121. GlaxoSmithKline Product
Table 122. GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Recent Development
Table 124. Glenmark Pharmaceuticals Company Details
Table 125. Glenmark Pharmaceuticals Business Overview
Table 126. Glenmark Pharmaceuticals Product
Table 127. Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 128. Glenmark Pharmaceuticals Recent Development
Table 129. Novartis Company Details
Table 130. Novartis Business Overview
Table 131. Novartis Product
Table 132. Novartis Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 133. Novartis Recent Development
Table 134. Roche Company Details
Table 135. Roche Business Overview
Table 136. Roche Product
Table 137. Roche Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 138. Roche Recent Development
Table 139. Sanofi Company Details
Table 140. Sanofi Business Overview
Table 141. Sanofi Product
Table 142. Sanofi Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 143. Sanofi Recent Development
Table 144. MSD Company Details
Table 145. MSD Business Overview
Table 146. MSD Product
Table 147. MSD Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 148. MSD Recent Development
Table 149. Astrazeneca Company Details
Table 150. Astrazeneca Business Overview
Table 151. Astrazeneca Product
Table 152. Astrazeneca Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 153. Astrazeneca Recent Development
Table 154. Takeda Company Details
Table 155. Takeda Business Overview
Table 156. Takeda Product
Table 157. Takeda Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 158. Takeda Recent Development
Table 159. North China Pharmaceutical Group Corporation Company Details
Table 160. North China Pharmaceutical Group Corporation Business Overview
Table 161. North China Pharmaceutical Group Corporation Product
Table 162. North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 163. North China Pharmaceutical Group Corporation Recent Development
Table 164. Huadong Medicine Company Details
Table 165. Huadong Medicine Business Overview
Table 166. Huadong Medicine Product
Table 167. Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 168. Huadong Medicine Recent Development
Table 169. Dongbao Pharmaceutical Company Details
Table 170. Dongbao Pharmaceutical Business Overview
Table 171. Dongbao Pharmaceutical Product
Table 172. Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 173. Dongbao Pharmaceutical Recent Development
Table 174. Hisun Pharmacy Company Details
Table 175. Hisun Pharmacy Business Overview
Table 176. Hisun Pharmacy Product
Table 177. Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 178. Hisun Pharmacy Recent Development
Table 179. KELUN Company Details
Table 180. KELUN Business Overview
Table 181. KELUN Product
Table 182. KELUN Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 183. KELUN Recent Development
Table 184. Ginwa Company Details
Table 185. Ginwa Business Overview
Table 186. Ginwa Product
Table 187. Ginwa Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 188. Ginwa Recent Development
Table 189. Tianan Pharmaceutical Company Details
Table 190. Tianan Pharmaceutical Business Overview
Table 191. Tianan Pharmaceutical Product
Table 192. Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 193. Tianan Pharmaceutical Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
Table 1. Diabetes Devices and Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Devices and Drugs Revenue
Table 3. Ranking of Global Top Diabetes Devices and Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Devices and Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diabetes Devices
Table 6. Key Players of Diabetes Drugs
Table 7. COVID-19 Impact Global Market: (Four Diabetes Devices and Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Diabetes Devices and Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Diabetes Devices and Drugs Players to Combat Covid-19 Impact
Table 12. Global Diabetes Devices and Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Diabetes Devices and Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Diabetes Devices and Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Diabetes Devices and Drugs Market Share by Regions (2015-2020)
Table 16. Global Diabetes Devices and Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Diabetes Devices and Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Diabetes Devices and Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Diabetes Devices and Drugs Players
Table 23. Global Diabetes Devices and Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Diabetes Devices and Drugs Market Share by Players (2015-2020)
Table 25. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2019)
Table 26. Global Diabetes Devices and Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Diabetes Devices and Drugs Product Solution and Service
Table 29. Date of Enter into Diabetes Devices and Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Diabetes Devices and Drugs Market Size Share by Type (2015-2020)
Table 33. Global Diabetes Devices and Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Diabetes Devices and Drugs Market Size Share by Application (2015-2020)
Table 35. Global Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Diabetes Devices and Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 39. North America Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 41. North America Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 45. Europe Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 47. Europe Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 51. China Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 53. China Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 57. Japan Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 59. Japan Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 63. Southeast Asia Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 69. India Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 71. India Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Diabetes Devices and Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Diabetes Devices and Drugs Market Share (2019-2020)
Table 75. Central & South America Diabetes Devices and Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Diabetes Devices and Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Diabetes Devices and Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Diabetes Devices and Drugs Market Share by Application (2015-2020)
Table 79. Medtronic Company Details
Table 80. Medtronic Business Overview
Table 81. Medtronic Product
Table 82. Medtronic Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 83. Medtronic Recent Development
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD Product
Table 87. BD Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 88. BD Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Product
Table 97. Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 98. Abbott Laboratories Recent Development
Table 99. Novo Nordisk Company Details
Table 100. Novo Nordisk Business Overview
Table 101. Novo Nordisk Product
Table 102. Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 103. Novo Nordisk Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. DexCom Company Details
Table 110. DexCom Business Overview
Table 111. DexCom Product
Table 112. DexCom Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 113. DexCom Recent Development
Table 114. Companion Medical Business Overview
Table 115. Companion Medical Product
Table 116. Companion Medical Company Details
Table 117. Companion Medical Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 118. Companion Medical Recent Development
Table 119. GlaxoSmithKline Company Details
Table 120. GlaxoSmithKline Business Overview
Table 121. GlaxoSmithKline Product
Table 122. GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Recent Development
Table 124. Glenmark Pharmaceuticals Company Details
Table 125. Glenmark Pharmaceuticals Business Overview
Table 126. Glenmark Pharmaceuticals Product
Table 127. Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 128. Glenmark Pharmaceuticals Recent Development
Table 129. Novartis Company Details
Table 130. Novartis Business Overview
Table 131. Novartis Product
Table 132. Novartis Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 133. Novartis Recent Development
Table 134. Roche Company Details
Table 135. Roche Business Overview
Table 136. Roche Product
Table 137. Roche Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 138. Roche Recent Development
Table 139. Sanofi Company Details
Table 140. Sanofi Business Overview
Table 141. Sanofi Product
Table 142. Sanofi Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 143. Sanofi Recent Development
Table 144. MSD Company Details
Table 145. MSD Business Overview
Table 146. MSD Product
Table 147. MSD Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 148. MSD Recent Development
Table 149. Astrazeneca Company Details
Table 150. Astrazeneca Business Overview
Table 151. Astrazeneca Product
Table 152. Astrazeneca Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 153. Astrazeneca Recent Development
Table 154. Takeda Company Details
Table 155. Takeda Business Overview
Table 156. Takeda Product
Table 157. Takeda Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 158. Takeda Recent Development
Table 159. North China Pharmaceutical Group Corporation Company Details
Table 160. North China Pharmaceutical Group Corporation Business Overview
Table 161. North China Pharmaceutical Group Corporation Product
Table 162. North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 163. North China Pharmaceutical Group Corporation Recent Development
Table 164. Huadong Medicine Company Details
Table 165. Huadong Medicine Business Overview
Table 166. Huadong Medicine Product
Table 167. Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 168. Huadong Medicine Recent Development
Table 169. Dongbao Pharmaceutical Company Details
Table 170. Dongbao Pharmaceutical Business Overview
Table 171. Dongbao Pharmaceutical Product
Table 172. Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 173. Dongbao Pharmaceutical Recent Development
Table 174. Hisun Pharmacy Company Details
Table 175. Hisun Pharmacy Business Overview
Table 176. Hisun Pharmacy Product
Table 177. Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 178. Hisun Pharmacy Recent Development
Table 179. KELUN Company Details
Table 180. KELUN Business Overview
Table 181. KELUN Product
Table 182. KELUN Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 183. KELUN Recent Development
Table 184. Ginwa Company Details
Table 185. Ginwa Business Overview
Table 186. Ginwa Product
Table 187. Ginwa Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 188. Ginwa Recent Development
Table 189. Tianan Pharmaceutical Company Details
Table 190. Tianan Pharmaceutical Business Overview
Table 191. Tianan Pharmaceutical Product
Table 192. Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020) (Million US$)
Table 193. Tianan Pharmaceutical Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Diabetes Devices and Drugs Market Share by Type: 2020 VS 2026
Figure 2. Diabetes Devices Features
Figure 3. Diabetes Drugs Features
Figure 4. Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2026
Figure 5. Diagnostic/Clinics Case Studies
Figure 6. ICUs Case Studies
Figure 7. Home Healthcare Case Studies
Figure 8. Diabetes Devices and Drugs Report Years Considered
Figure 9. Global Diabetes Devices and Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Diabetes Devices and Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Diabetes Devices and Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Diabetes Devices and Drugs Market Share by Players in 2019
Figure 14. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2019
Figure 16. North America Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Medtronic Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 25. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BD Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 27. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Johnson & Johnson Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 31. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novo Nordisk Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 33. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 35. DexCom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. DexCom Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 37. Companion Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Companion Medical Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 39. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 41. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Glenmark Pharmaceuticals Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 43. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Novartis Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 45. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Roche Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 47. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Sanofi Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 49. MSD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. MSD Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 51. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Astrazeneca Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 53. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Takeda Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 55. North China Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 57. Huadong Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Huadong Medicine Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 59. Dongbao Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Dongbao Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 61. Hisun Pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Hisun Pharmacy Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Global Diabetes Devices and Drugs Market Share by Type: 2020 VS 2026
Figure 2. Diabetes Devices Features
Figure 3. Diabetes Drugs Features
Figure 4. Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2026
Figure 5. Diagnostic/Clinics Case Studies
Figure 6. ICUs Case Studies
Figure 7. Home Healthcare Case Studies
Figure 8. Diabetes Devices and Drugs Report Years Considered
Figure 9. Global Diabetes Devices and Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Diabetes Devices and Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Diabetes Devices and Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Diabetes Devices and Drugs Market Share by Players in 2019
Figure 14. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2019
Figure 16. North America Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Diabetes Devices and Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Medtronic Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 25. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BD Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 27. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Johnson & Johnson Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 31. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novo Nordisk Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 33. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 35. DexCom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. DexCom Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 37. Companion Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Companion Medical Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 39. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 41. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Glenmark Pharmaceuticals Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 43. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Novartis Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 45. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Roche Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 47. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Sanofi Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 49. MSD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. MSD Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 51. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Astrazeneca Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 53. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Takeda Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 55. North China Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 57. Huadong Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Huadong Medicine Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 59. Dongbao Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Dongbao Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 61. Hisun Pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Hisun Pharmacy Revenue Growth Rate in Diabetes Devices and Drugs Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
